MFAP5 and neoplasm: In vivo assays, MFAP5 promoted tumor progression by increasing angiogenesis, tumor growth, invasion, and metastasis (84) and MFAP5 blockade using monoclonal antibodies was able to inhibit fibrosis and enhance chemosensitivity in mouse models, generating tumor suppression (119).